These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22657157)

  • 21. High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma.
    Porta F; Kaloudi O; Garzitto A; Prignano F; Nacci F; Falcini F; Matucci Cerinic M
    Mod Rheumatol; 2014 Sep; 24(5):869-73. PubMed ID: 24251994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry.
    Klein A; Kaul I; Foeldvari I; Ganser G; Urban A; Horneff G
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1349-56. PubMed ID: 22649024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR; Sato EI
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate and corticosteroid therapy for pediatric localized scleroderma.
    Uziel Y; Feldman BM; Krafchik BR; Yeung RS; Laxer RM
    J Pediatr; 2000 Jan; 136(1):91-5. PubMed ID: 10636981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
    Ramanan AV; Campbell-Webster N; Ota S; Parker S; Tran D; Tyrrell PN; Cameron B; Spiegel L; Schneider R; Laxer RM; Silverman ED; Feldman BM
    Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study.
    Torok KS; Arkachaisri T
    J Rheumatol; 2012 Feb; 39(2):286-94. PubMed ID: 22247357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juvenile localised scleroderma: a retrospective review of response to systemic treatment.
    Cox D; O' Regan G; Collins S; Byrne A; Irvine A; Watson R
    Ir J Med Sci; 2008 Dec; 177(4):343-6. PubMed ID: 18941862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma.
    Li SC; Torok KS; Ishaq SS; Buckley M; Edelheit B; Ede KC; Liu C; Rabinovich CE
    Rheumatology (Oxford); 2021 Aug; 60(8):3817-3825. PubMed ID: 33369667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The methotrexate therapeutic response in rheumatoid arthritis.
    Ortendahl M; Holmes T; Schettler JD; Fries JF
    J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
    Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
    Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
    J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
    Li SC; Fuhlbrigge RC; Laxer RM; Pope E; Ibarra MF; Stewart K; Mason T; Becker ML; Hong S; Dedeoglu F; Torok KS; Rabinovich CE; Ferguson PJ; Punaro M; Feldman BM; Andrews T; Higgins GC;
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):43. PubMed ID: 31307476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study.
    Du-Thanh A; Merlet S; Maillard H; Bernard P; Joly P; Estève E; Richard MA; Pauwels C; Ingen-Housz-Oro S; Guillot B; Dereure O
    Br J Dermatol; 2011 Dec; 165(6):1337-43. PubMed ID: 21777222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
    Lémann M; Zenjari T; Bouhnik Y; Cosnes J; Mesnard B; Rambaud JC; Modigliani R; Cortot A; Colombel JF
    Am J Gastroenterol; 2000 Jul; 95(7):1730-4. PubMed ID: 10925976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris.
    Baum S; Greenberger S; Samuelov L; Solomon M; Lyakhovitsky A; Trau H; Barzilai A
    Eur J Dermatol; 2012; 22(1):83-7. PubMed ID: 22266247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New developments in juvenile systemic and localized scleroderma.
    Foeldvari I
    Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
    Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
    Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.
    Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Maximov A; Vorontsov I; Fink CW; Newman AJ; Cassidy JT; Zemel LS
    N Engl J Med; 1992 Apr; 326(16):1043-9. PubMed ID: 1549149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.